2020
DOI: 10.1001/jama.2019.21472
|View full text |Cite
|
Sign up to set email alerts
|

Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
5
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Pathogens such as vancomycin-resistant Enterococcus faecium and multidrug-resistant Staphylococcus aureus , which are on the CDC’s list of serious threats, could jeopardize health care systems because there are limited defenses against them , and there is a potential of transferring chemical resistance to more dangerous pathogens . Combinatorial treatments that target multiple bacterial pathways or enhance drug activity are currently used, for example the coadministration of amoxicillin and clavulanic acid to treat β-lactamase-producing S. aureus and, despite some controversy, combinations of vancomycin with β-lactams or daptomycin as a last resort therapy. Finding compounds that act in synergistic ways might improve our chances of fighting AR and, in turn, our ability to combat infectious diseases.…”
mentioning
confidence: 99%
“…Pathogens such as vancomycin-resistant Enterococcus faecium and multidrug-resistant Staphylococcus aureus , which are on the CDC’s list of serious threats, could jeopardize health care systems because there are limited defenses against them , and there is a potential of transferring chemical resistance to more dangerous pathogens . Combinatorial treatments that target multiple bacterial pathways or enhance drug activity are currently used, for example the coadministration of amoxicillin and clavulanic acid to treat β-lactamase-producing S. aureus and, despite some controversy, combinations of vancomycin with β-lactams or daptomycin as a last resort therapy. Finding compounds that act in synergistic ways might improve our chances of fighting AR and, in turn, our ability to combat infectious diseases.…”
mentioning
confidence: 99%
“…In the early stage, it was mainly treated in combination with other antibiotics, such as streptomycin and penicillin. The combination of antibiotics has a synergistic effect, which not only has better efficacy than a single drug, but also can inhibit the drug resistance selection of a single drug ( 45 , 46 ). With the development of multi-drug resistant bacteria, antibiotic substitutes ( 47 ) such as phage therapy ( 48 50 ), nanomaterials ( 51 54 ), bacteriocins ( 55 ), antibodies, and probiotics ( 56 ) have been attracted more attention.…”
Section: Introductionmentioning
confidence: 99%
“…At present, various commercially available antimicrobial drugs exhibit some prominent defects, including nonspecific targeting and low concentrations in the lesion, which leads to low efficiency, high toxicity, various side effects 15 and multidrug resistance. 16 , 17 In the era of precision medicine, targeted drug design has been intensively developed, 18 and high efficiency and sufficient safety have become the main goals for targeted drug design. 19 Therefore, it is important to develop a targeted antimicrobial drug delivery system as a novel strategy for the prevention and treatment of sepsis.…”
Section: Introductionmentioning
confidence: 99%